Express News | Novocure Ltd - Appoints Ashley Cordova as CEO Effective Jan 1, 2025

BreakingsDec 17 19:03

NovoCure Shares Are Trading Higher After Piper Sandler Maintained an Overweight Rating on the Stock and Raised Its Price Target From $28 to $42.

BenzingaDec 14 04:49

Novocure Is Maintained at Overweight by Piper Sandler

Dow JonesDec 13 21:23 · Ratings

NovoCure Analyst Ratings

BenzingaDec 13 21:12 · Ratings

Piper Sandler Maintains Novocure(NVCR.US) With Buy Rating, Raises Target Price to $42

Futu NewsDec 13 20:31 · Ratings

Analysts Have Conflicting Sentiments on These Healthcare Companies: Sanofi (OtherSNYNF) and NovoCure (NVCR)

TipRanksDec 10 20:11 · Ratings